REQUEST A DEMO
Total
USD $0.00
Search more companies

Instytut Badawczy Innowacyjno Rozwojowy Biotomed Sp. z o.o. (Poland)

Main Activities: All Other Miscellaneous Ambulatory Health Care Services
Full name: Instytut Badawczy Innowacyjno Rozwojowy Biotomed Sp. z o.o. Profile Updated: January 06, 2021
Buy our report for this company USD 19.99 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Instytut Badawczy Innowacyjno Rozwojowy Biotomed Sp. z o.o. is an enterprise in Poland, with the main office in Bialystok. It operates in the All Other Miscellaneous Ambulatory Health Care Services industry. The company was established on October 12, 2018. The latest financial highlights indicate a net sales revenue drop of 39.71% in 2023. Its total assets decreased by 11.56% over the same period. The net profit margin of Instytut Badawczy Innowacyjno Rozwojowy Biotomed Sp. z o.o. decreased by 71.45% in 2023.

Headquarters
Ul. Krakowska 9
Bialystok; Podlaskie; Postal Code: 15-875

Contact Details: Purchase the Instytut Badawczy Innowacyjno Rozwojowy Biotomed Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Instytut Badawczy Innowacyjno Rozwojowy Biotomed Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Instytut Badawczy Innowacyjno Rozwojowy Biotomed Sp. z o.o. report to view the information.
Incorporation Date:
October 12, 2018
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Instytut Badawczy Innowacyjno Rozwojowy Biotomed Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-39.71%
Total operating revenue
-39.71%
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
-2599.16%
Total assets
-11.56%
Total equity
-641.43%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
-71.45%
Return on Equity (ROE)
62.75%
Debt to Equity Ratio
1680.67%
Quick Ratio
-34.51%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?